TAMPA, Fla.--(BUSINESS WIRE)--Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”) today announced the initiation of a Good Laboratory Practice (GLP) toxicology study to evaluate the ...
Congressional Democrats yesterday expressed outrage that the Department of Health and Human Services still hasn’t published a toxicology study that a White House official earlier this year described ...
IM1240 demonstrated improved safety in a toxicology study at doses up to 300-fold higher than a non-capped comparator IM1240's pharmacokinetic profile showed increased systemic exposure and a ...
– SL-325 is a high-affinity DR3 blocking antibody being developed for the treatment of inflammatory bowel disease (IBD); No evidence of toxicity or residual agonism observed in non-human primate ...
LONDON, Dec. 16, 2020 /PRNewswire/ -- PrEP Biopharm Limited, a private drug company developing treatments for respiratory infectious diseases, announced that it has successfully completed a 12-week ...
Grand Cayman, Cayman Islands, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology company developing RNA ...
Results from this study showed CAP-003 was well tolerated with no adverse clinical observations or adverse histopathology findings. "We're excited by the emerging data from our GLP toxicology study ...
COLLEGE STATION, TX / ACCESSWIRE / October 5, 2022 / Enzolytics, Inc. (OTC PINK:ENZC) ("ENZC" or the "Company"). The Company announces the completion of the first phase of the animal toxicology ...
Altasciences is pleased to have been chosen by Steel Therapeutics, Inc. (“Steel”), to initiate a pivotal toxicology study for Fizurex™, a novel topical therapy for the treatment of anal fissures. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results